Text Size
- News Releases
- What's New
- 14 Jun
- Chugai and Mitsubishi Logistics Enter into Service Agreement for Logistics Operations
- 03 Jun
- Chugai Files for Additional Indication of ALK Inhibitor ALECENSA for Recurrent or Refractory ALK Fusion Gene-Positive Anaplastic Large Cell Lymphoma (ALCL)
- 03 Jun
- Final Progression-Free Survival Data and the Second Interim Analysis of Overall Survival from the J-ALEX Study for Alecensa Presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
- 03 Jun
- Chugai Launches Genomic Mutation Analysis Program, FoundationOne CDx Cancer Genomic Profile
- 31 May
- Chugai Conducts Educational Campaign to Promote Cervical Cancer Screening Across Japan with Local Governments and Other Partners
Video Introduction of CHUGAI- Share this site
